Haro, I.; Castellanos-Moreira, R.; SanmartÃ, R.; Gómara, M.J.
Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides. Diagnostics 2024, 14, 2485.
https://doi.org/10.3390/diagnostics14222485
AMA Style
Haro I, Castellanos-Moreira R, Sanmartà R, Gómara MJ.
Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides. Diagnostics. 2024; 14(22):2485.
https://doi.org/10.3390/diagnostics14222485
Chicago/Turabian Style
Haro, Isabel, Raul Castellanos-Moreira, Raimon SanmartÃ, and MarÃa José Gómara.
2024. "Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides" Diagnostics 14, no. 22: 2485.
https://doi.org/10.3390/diagnostics14222485
APA Style
Haro, I., Castellanos-Moreira, R., SanmartÃ, R., & Gómara, M. J.
(2024). Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides. Diagnostics, 14(22), 2485.
https://doi.org/10.3390/diagnostics14222485